Breakthrough Prizes Recognize Aneuploidy Researcher, Biochemist
Breakthrough Prizes Recognize Aneuploidy Researcher, Biochemist
This year’s winners also include the developers of nusinersen, an oligonucleotide therapeutic for spinal muscular atrophy.
Breakthrough Prizes Recognize Aneuploidy Researcher, Biochemist
Breakthrough Prizes Recognize Aneuploidy Researcher, Biochemist

This year’s winners also include the developers of nusinersen, an oligonucleotide therapeutic for spinal muscular atrophy.

This year’s winners also include the developers of nusinersen, an oligonucleotide therapeutic for spinal muscular atrophy.

oligonucleotides
Custom-Made Molecules
Custom-Made Molecules
Ruth Williams | Aug 21, 2017
A new prototype machine can make the biological molecules of one’s choice from digital DNA sequences.
FDA Approves First Treatment for Spinal Muscular Atrophy
FDA Approves First Treatment for Spinal Muscular Atrophy
Ben Andrew Henry | Dec 28, 2016
The oligonucleotide therapeutic will soon be available in the U.S.
Oligonucleotide Therapeutics Near Approval
Oligonucleotide Therapeutics Near Approval
Catherine Offord | Dec 1, 2016
Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.
Speaking of Neuroscience
Speaking of Neuroscience
Jef Akst, Mary Beth Aberlin | Nov 18, 2016
A selection of notable quotes from the annual Society for Neuroscience meeting